Bellus Total Debt

BLU
 Stock
  

USD 10.40  0.36  3.35%   

Bellus Health fundamentals help investors to digest information that contributes to Bellus Health's financial success or failures. It also enables traders to predict the movement of Bellus Stock. The fundamental analysis module provides a way to measure Bellus Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellus Health stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Bellus Total Debt Analysis

Bellus Health's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Total Debt 
 = 
Bonds 
+  
Notes 
More About Total Debt | All Equity Analysis

Current Bellus Health Total Debt

    
  845 K  
Most of Bellus Health's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bellus Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Based on the latest financial disclosure, Bellus Health has a Total Debt of 845 K. This is 99.97% lower than that of the Healthcare sector and 99.74% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.98% higher than that of the company.

Bellus Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellus Health's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellus Health could also be used in its relative valuation, which is a method of valuing Bellus Health by comparing valuation metrics of similar companies.
Bellus Health is currently under evaluation in total debt category among related companies.

Bellus Health Institutional Holders

Institutional Holdings refers to the ownership stake in Bellus Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bellus Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bellus Health's value.
Security TypeSharesValue
Ra Capital Management LpCommon Shares10.2 M94.5 M
Artal Group SaCommon SharesM64.7 M
Goldman Sachs Group IncCommon Shares6.4 M58.9 M
Perceptive Advisors LlcCommon Shares5.5 M51.1 M
Laurion Capital Management LpCommon Shares5.3 M49.1 M
Power Corp Of CanadaCommon Shares4.9 M45.6 M
Citadel Advisors LlcCommon Shares4.6 M42.2 M

Bellus Fundamentals

About Bellus Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bellus Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellus Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bellus Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Pair Trading with Bellus Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bellus Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bellus Health

+0.63CVXChevron Corp TrendingPairCorr
The ability to find closely correlated positions to Bellus Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellus Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellus Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellus Health to buy it.
The correlation of Bellus Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bellus Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bellus Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bellus Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Bellus Health Piotroski F Score and Bellus Health Altman Z Score analysis. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.